PLT Health Solutions, Inc. and innovation partner Nektium Pharma announced the completion of a new clinical study on its award-winning Zynamite® S ingredient. This study showed a broad range of energy ...
The company plans to conduct a three-year study of Parkinson's risk among people with essential tremor, using its Syn-One Test.
2don MSN
Praxis Precision Medicines Reports Positive Phase 3 Results for Ulixacaltamide in Essential Tremor
Praxis Precision Medicines Inc. (NASDAQ: PRAX) is one of the Reddit stocks that will go to the moon. On October 16, Praxis ...
I read your recent column where you said that ivermectin has not been proven to be an effective treatment for cancer. I feel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback